WEF-001
/ Auricula Biosciences, Syndivia
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
February 18, 2026
WEF-001-01: A study to investigate WEF-001 in patients with Advanced KRAS-Mutant Solid Tumours.
(clinicaltrialsregister.eu)
- P1/2 | N=27 | Not yet recruiting | Sponsor: Auricula Biosciences Inc.
New P1/2 trial • Cholangiocarcinoma • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Ovarian Cancer • Ovarian Serous Adenocarcinoma • Solid Tumor • KRAS • MSI
1 to 1
Of
1
Go to page
1